ChromaCode Announces Landmark Peer-Reviewed Publication on Breakthrough HDPCR Assay for Non-Small-Cell Lung Cancer
/PRNewswire/ -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients...